Lack of association between cervical dysplasia and IBD: A large case-control study

Inflammatory Bowel Diseases

Volumn 15, Issue 11, 2009, Pages 1621-1629

  Lees, C W ^a   Critchley, J ^a   Chee, N ^a   Beez, T ^a   Gailer, R E ^a   Williams, A R ^b   Shand, A G ^a   Arnott, I D R ^a   Satsangi, J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer; Cervical dysplasia; Crohn's disease; Immunosuppression; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER IMMUNIZATION; CIGARETTE SMOKING; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; ULCERATIVE COLITIS; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CONTRACEPTIVES, ORAL; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SCOTLAND; SMOKING; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 72549095691     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20959     Document Type: Article

References (40)

1. Cancer Research UK. http:/info.cancerresearchuk.org/cancerstats/types/ cervix/?a=5441 2008.
2. Information Services Division Scotland. Cancer of the Cervix Uterii (ICD-10). http://www.isdscotland.org/isd/183.html 2008.
3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517. (Pubitemid 38649869)
4. Viget N, Vernier-Massouille G, Salmon-Ceron D, et al. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut. 2008;57:549-558.
5. Gupta PK, Pinn VM, Taft PD. Cervical dysplasia associated with azathioprine (Imuran) therapy. Acta Cytol. 1969;13:373-376.
6. Munoz N, Bosch X, Kaldor JM. Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer. 1988;57:1-5. (Pubitemid 18067096)
7. Zur HH. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol. 1977;78:1-30.
8. Cordiner JW, Sharp F, Briggs JD. Cervical intraepithelial neoplasia in immunosuppressed women after renal transplantation. Scott Med J. 1980;25:275-277. (Pubitemid 11222870)
9. Kay S, Frable WJ, Hume DM. Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation. Cancer. 1970;26:1048-1052.
10. Leckie GB, Cotton RE. Simultaneous in situ carcinoma of the cervix, vulva and perineum after immunosuppressive therapy for renal transplantation. Br J Obstet Gynaecol. 1977;84:143-148.
11. Porreco R, Penn I, Droegemueller W, et al. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol. 1975;45:359-364.
12. Tallent MB, Simmons RL, Najarian JS. Primary carcinoma of the cervix appearing in immunosuppressed renal transplant recipient. Am J Obstet Gynecol. 1971;109:663-664.
13. Kreiss JK, Kiviat NB, Plummer FA, et al. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex Transm Dis. 1992;19:54-59.
14. Laga M, Icenogle JP, Marsella R, et al. Genital papillomavirus infection and cervical dysplasia - opportunistic complications of HIV infection. Int J Cancer. 1992;50:45-48.
15. Marte C, Kelly P, Cohen M, et al. Papanicolaou smear abnormalities in ambulatory care sites for women infected with the human immunodeficiency virus. Am J Obstet Gynecol. 1992;166:1232-1237.
16. Wright TC Jr, Ellerbrock TV, Chiasson MA, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol. 1994;84:591-597.
17. Chin KM, Sidhu JS, Janssen RS, et al. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients. Obstet Gynecol. 1998;92:83-87.
18. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283:1031-1037. (Pubitemid 30112217)
19. Bateman H, Yazici Y, Leff L, et al. Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study. Lupus. 2000;9:542-544. (Pubitemid 30701457)
20. Blumenfeld Z, Lorber M, Yoffe N, et al. Systemic lupus erythematosus: predisposition for uterine cervical dysplasia. Lupus. 1994;3:59-61. (Pubitemid 24105472)
21. Dhar JP, Kmak D, Bhan R, et al. Abnormal cervicovaginal cytology in women with lupus: a retrospective cohort study. Gynecol Oncol. 2001;82:4-6. (Pubitemid 32634945)
22. Nyberg G, Eriksson O, Westberg NG. Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arthritis Rheum. 1981;24:648-650. (Pubitemid 11099278)
23. Ognenovski VM, Marder W, Somers EC, et al. Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. J Rheumatol. 2004;31:1763-1767. (Pubitemid 39202518)
24. Connell WR, Kamm MA, Dickson M, et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet. 1994;343:1249-1252. (Pubitemid 24158045)
25. Bhatia J, Bratcher J, Korelitz B, et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol. 2006;12:6167-6171. (Pubitemid 44688166)
26. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103:631-636.
27. Singh H, Demers AA, Nugent Z, et al. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology. 2009;136:451-458.
28. Evans DM, Hudson EA, Brown CL, et al. Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology. J Clin Pathol. 1986;39:933-944.
29. National Institute for Clinical Excellence. Guidance on the use of liquid-based cytology for cervical screening. http://www.nice.org.uk/nicemedia/ pdf/TA69-LBC-review-FullGuidance.pdf 2008.
30. Castellsague X, Munoz N. Chapter 3: cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003:20-28.
31. Raffle AE, Alden B, Quinn M, et al.Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ. 2003;326:901.
32. Sirovich BE, Welch HG. The frequency of Pap smear screening in the United States. J Gen Intern Med. 2004;19:243-250.
33. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000;23:101-113.
34. Nath R, Mant C, Luxton J, et al. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum. 2007;57:619-625. (Pubitemid 46764052)
35. Tam LS, Chan AY, Chan PK, et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum. 2004;50:3619-3625.
36. Slattery ML, Robison LM, Schuman KL, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA. 1989;261:1593-1598.
37. Winkelstein W Jr. Smoking and cervical cancer - current status: a review. Am J Epidemiol. 1990;131:945-957. (Pubitemid 20178615)
38. Bosch FX, de SS. Chapter 1: human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;:3-13.
39. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265:472-477.
40. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423-428.